Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis

Cancer Research

Volumn 71, Issue 6, 2011, Pages 2350-2359

  Crone, Johanna ^a   Glas, Carolina ^a   Schultheiss, Kathrin ^a   Moehlenbrink, Jutta ^a   Krieghoff Henning, Eva ^a   Hofmann, Thomas G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE; DOXORUBICIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PROTEASOME; PROTEIN P53; PROTEIN SIAH 1; SERINE; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; ZYXIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL FATE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSKELETON; DEPLETION; DIMERIZATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DNA DAMAGE; ENZYME ACTIVATION; GLYCOPROTEINS; HEK293 CELLS; HEP G2 CELLS; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERINE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 79952753170     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3486     Document Type: Article

References (44)

1. Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007; 26:7773-9. (Pubitemid 350242463)
2. Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 2008;9:297-308. (Pubitemid 351430844)
3. Bitomsky N, Hofmann TG. Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2. FEBS J 2009;276:6074-83.
4. Sombroek D, Hofmann TG. How cells switch HIPK2 on and off. Cell Death Differ 2009;16:187-94.
5. Calzado MA, Renner F, Roscic A, Schmitz ML. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007;6:139-43. (Pubitemid 46232491)
6. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008;10:812-24. (Pubitemid 351927710)
7. Choi DW, Seo YM, Kim EA, Sung KS, Ahn JW, Park SJ, et al. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J Biol Chem 2008;283:4682-9.
8. Kim SY, Choi DW, Kim EA, Choi CY. Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Letters 2009;279:177-84.
9. Dauth I, Kruger J, Hofmann TG. Homeodomain-Interacting Protein Kinase 2 Is the Ionizing Radiation-Activated p53 Serine 46 Kinase and Is Regulated by ATM. Cancer Res 2007;67:2274-9. (Pubitemid 46424247)
10. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002;4:1-10. (Pubitemid 34071974)
11. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002;4:11-9.
12. Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G. Homeodomain- interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp Cell Res 2004;293:311-20. (Pubitemid 38083221)
13. Moller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Droge W, et al. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 2003;63:4310-4. (Pubitemid 36950995)
14. Hofmann TG, Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ 2003;10:1290-9. (Pubitemid 37536734)
15. Bernardi R, Pandolfi PP. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 2003;22:9048-57.
16. Krieghoff-Henning E, Hofmann TG. Role of nuclear bodies in apoptosis signalling. Biochim Biophys Acta 2008;1783:2185-94.
17. Dellaire G, Bazett-Jones DP. Beyond repair foci: subnuclear domains and the cellular response to DNA damage. Cell Cycle 2007;6:1864-72. (Pubitemid 47327904)
18. Kadrmas JL, Beckerle MC. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 2004;5:920-31. (Pubitemid 39486543)
19. Nix DA, Fradelizi J, Bockholt S, Menichi B, Louvard D, Friederich E, et al. Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 2001;276:34759-67.
20. Hoffman LM, Jensen CC, Kloeker S, Wang CL, Yoshigi M, Beckerle MC. Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling. J Cell Biol 2006;172:771-82.
21. Nix DA, Beckerle MC. Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J Cell Biol 1997;138:1139-47. (Pubitemid 27386462)
22. Hervy M, Hoffman L, Beckerle MC. From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr Opin Cell Biol 2006;18:524-32. (Pubitemid 44332910)
23. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembitski CC, et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 2005;115:2716-30. (Pubitemid 41434399)
24. Yoshigi M, Hoffman LM, Jensen CC, Yost HJ, Beckerle MC. Mechanical force mobilizes zyxin from focal adhesions to actin filaments and regulates cytoskeletal reinforcement. J Cell Biol 2005;171:209-15. (Pubitemid 41540014)
25. Cerisano V, Aalto Y, Perdichizzi S, Bernard G, Manara MC, Benini S, et al. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene 2004;23:5664-74. (Pubitemid 39093044)
26. Chan CB, Liu X, Tang X, Fu H, Ye K. Akt phosphorylation of zyxin mediates its interaction with acinus-S and prevents acinus-triggered chromatin condensation. Cell Death Differ 2007;14:1688-99. (Pubitemid 47278854)
27. Pierantoni GM, Fedele M, Pentimalli F, Benvenuto G, Pero R, Viglietto G, et al. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 2001;20:6132-41. (Pubitemid 32964425)
28. Pierantoni GM, Rinaldo C, Mottolese M, Di Benedetto A, Esposito F, Soddu S, et al. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 2007;117:693-702. (Pubitemid 46348527)
29. Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, et al. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene 2007;26:7231-9. (Pubitemid 350085316)
30. Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J, et al. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci U S A 2007; 104:13040-5. (Pubitemid 351737589)
31. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsy M, Childs G, et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002;62:6973-80. (Pubitemid 35424089)
32. Amsellem V, Kryszke MH, Hervy M, Subra F, Athman R, Leh H, et al. The actin cytoskeleton-associated protein Zyxin acts as a tumor suppressor in Ewing tumor cells. Exp Cell Res 2005;304:443-56. (Pubitemid 40321122)
33. Yu YP, Luo JH. Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin. Cancer Res 2006; 66:7414-9. (Pubitemid 44289193)
34. Hofmann TG, Jaffray E, Stollberg N, Hay RT, Will H. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J Biol Chem 2005;280:29224-32. (Pubitemid 41161375)
35. Moehlenbrink J, Bitomsky N, Hofmann TG. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation. Cancer Letters 2009;292:119-24.
36. Matsuzawa S, Li C, Ni CZ, Takayama S, Reed JC, Ely KR. Structural analysis of Siah1 and its interactions with Siah-interacting protein (SIP). J Biol Chem 2003;278:1837-40. (Pubitemid 36801421)
37. Polekhina G, House CM, Traficante N, Mackay JP, Relaix F, Sassoon DA, et al. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat Struct Biol 2002;9:68-75. (Pubitemid 34049183)
38. Van Der Gaag EJ, Leccia MT, Dekker SK, Jalbert NL, Amodeo DM, Byers HR. Role of Zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. The Journal of investigative dermatology 2002;118:246-54. (Pubitemid 34158477)
39. Drees BE, Andrews KM, Beckerle MC. Molecular dissection of zyxin function reveals its involvement in cell motility. J Cell Biol 1999; 147:1549-60.
40. Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer 2009;9:206-16.
41. House CM, Moller A, Bowtell DD. Siah proteins: novel drug targets in the Ras and hypoxia pathways. Cancer Res 2009;69:8835-8.
42. Wang W, Huper G, Guo Y, Murphy SK, Olson JA Jr., Marks JR. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene 2005; 24:2705-14. (Pubitemid 40593098)
43. Hofmann TG, Stollberg N, Schmitz ML, Will H. HIPK2 Regulates Transforming Growth Factor-beta-Induced c-Jun NH(2)-Terminal Kinase Activation and Apoptosis in Human Hepatoma Cells. Cancer Res 2003;63:8271-7.
44. Milovic-Holm K, Krieghoff E, Jensen K, Will H, Hofmann TG. FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J 2007;26:391-401. (Pubitemid 46160940)